Your browser doesn't support javascript.
loading
Utility of the Polestar N30 low-field MRI system for resecting non-enhancing intra-axial brain lesions.
Ungar, Lior; Zibly, Zion; Wohl, Anton; Harel, Ran; Hadani, Moshe; Attia, Moshe; Spiegelmann, Roberto; Feldman, Zeev; Zaubermann, Jacob; Knoller, Nachshon; Cohen, Zvi R.
Affiliation
  • Ungar L; Sackler School of Medicine, Tel Aviv University, Israel.
  • Zibly Z; Sackler School of Medicine, Tel Aviv University, Israel.
  • Wohl A; Sackler School of Medicine, Tel Aviv University, Israel.
  • Harel R; Sackler School of Medicine, Tel Aviv University, Israel.
  • Hadani M; Sackler School of Medicine, Tel Aviv University, Israel.
  • Attia M; Sackler School of Medicine, Tel Aviv University, Israel.
  • Spiegelmann R; Sackler School of Medicine, Tel Aviv University, Israel.
  • Feldman Z; Sackler School of Medicine, Tel Aviv University, Israel.
  • Zaubermann J; Sackler School of Medicine, Tel Aviv University, Israel.
  • Knoller N; Sackler School of Medicine, Tel Aviv University, Israel.
  • Cohen ZR; Sackler School of Medicine, Tel Aviv University, Israel. zvi.cohen@sheba.health.gov.il.
Neurol Neurochir Pol ; 55(2): 202-211, 2021.
Article in En | MEDLINE | ID: mdl-33559873
BACKGROUND: To determine the utility of an intraoperative magnetic resonance imaging (iMRI) system, the Polestar N30, for enhancing the resection control of non-enhancing intra-axial brain lesions. MATERIALS AND METHODS: Seventy-three patients (60 males [83.3%], mean age 37 years) with intra-axial brain lesions underwent resection at Sheba Medical Centre using the Polestar between February 2012 and the end of August 2018. Demographic and imaging data were retrospectively analysed. Thirty-five patients had a non-enhancing lesion (48%). RESULTS: Complete resection was planned for 60/73 cases after preoperative imaging. Complete resection was achieved in 59/60 (98.3%) cases. After iMRI, additional resection was performed in 24/73 (32.8%) cases, and complete resection was performed in 17/60 (28.8%) cases in which a complete resection was intended. In 6/13 (46%) patients for whom incomplete resection was intended, further resection was performed. The extent of resection was extended mainly for non-enhancing lesions: 16/35 (46%) as opposed to only 8/38 (21%) for enhancing lesions. Further resection was not significantly associated with sex, age, intended resection, recurrence, or affected side. Univariate analysis revealed non-eloquent area, intended complete resection, and enhancing lesions to be predictive factors for complete resection, and non-enhancing lesions and scan time to be predictive factors for an extended resection. Non-enhancement was the only independent factor for extended resection. CONCLUSIONS: The Polestar N30 is useful for evaluating residual non-enhancing intra-axial brain lesions and achieving maximal resection.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: Neurol Neurochir Pol Year: 2021 Document type: Article Affiliation country: Israel Country of publication: Poland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: Neurol Neurochir Pol Year: 2021 Document type: Article Affiliation country: Israel Country of publication: Poland